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Summary  The  aim  of  the  present  study  was  to  determine  the  frequency  of  hep-
atitis  B  and  C  transmission  to  health  care  workers  (HCWs)  in  ﬁve  major  hospitals  in
eastern  Libya  and  to  analyze  how  the  risk  of  these  infections  are  affected  by  the
type  of  occupation,  hospital  work  place  and  working  period.  From  July  2008  to  June
2009,  601  HCWs  (mean  age:  32.90  ±  8.85  years)  were  tested  for  HBV  and  HCV  mark-
ers  using  ELISA  techniques.  Polymerase  chain  reaction  (PCR)  was  performed  on  all
positive  samples  of  HBsAg  and  Anti-HCV  antibody  to  determine  the  level  of  HBV-DNA
and  HCV-RNA  viremia,  respectively.  The  overall  frequency  of  HBsAg  positivity  was
1.8%.  Anti-HBc,  HBeAg  and  Anti-HBe  antibodies  were  found  in  8.5%,  0.7%  and  8.0%  of
samples,  respectively.  The  HBV-DNA  level  was  positive  in  55%  of  all  HBsAg-positive
samples.  Approximately  half  of  the  HCWs  (51.4%)  were  Anti-HBs  antibody  posi-
tive.  The  overall  positivity  rate  of  Anti-HCV  antibodies  was  2.0%,  and  HCV-RNA  was
positive  in  33.3%  of  these  samples.  Overall,  52%  of  HCWs  reported  receiving  full  vac-
cination  doses  (three  doses)  against  HBV  infection.  Among  them,  anti-HBs  positivity
was  approximately  98.0%.  3.9%  of  those  who  never  received  any  HBV  vaccination
dose  were  HBsAg  positive,  compared  to  1.3%  HBsAg  positive  in  those  HCWs  who
had  received  one  or  two  doses  of  hepatitis  B  vaccine  (p  =  0.01  for  all  comparisons).
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Nurses  and  nurse-aides  had  the  highest  rates  of  both  HBsAg  and  Anti-HCV  among
the  studied  HCWs  (HBsAg:  2.1%  and  3.2%;  Anti-HCV:  3.2%  and  4.9%,  respectively).  It  is
noteworthy  that  doctors  also  had  a  relatively  high  prevalence  rate  of  Anti-HCV  (2.2%).
Obstetric  wards,  isolation  room,  dialysis  units  and  dentist  work  places  had  higher
frequencies  of  HBV.  HCV  was  found  to  be  higher  in  the  medical  and  surgical  wards  (the
prevalence  varied  between  3%  and  5.6%).  There  was  no  signiﬁcant  difference  between
HBsAg  status  and  the  work  period  of  HCWs.  In  conclusion,  universal  precautions  should
be  applied  for  the  care  of  all  patients  by  all  HCWs.  Further,  HBV  vaccines  should  be
or  Libyan  HCWs  by  reinforcing  current  vaccination  programs.
dulaziz  University  for  Health  Sciences.  Published  by  Elsevier
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medical  assistants,  and  cleaners.  They  were  ran-
domly selected  from  different  places  of  work
in these  hospitals  to  include  operation  theaters,more  readily  available  f
©  2014  King  Saud  Bin  Ab
Ltd.  All  rights  reserved.
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epatitis  B  virus  (HBV)  and  hepatitis  C  virus  (HCV)
re among  the  main  causes  of  liver-associated  dis-
ases, including  liver  cirrhosis  and  hepatocellular
arcinoma [1,2]. Both  viruses  are  major  global  pub-
ic health  problems  warranting  high  priority  efforts
or prevention,  control  and  treatment.  Approxi-
ately two  billion  individuals  worldwide  have  been
nfected by  HBV,  and  between  350  and  400  million
ndividuals have  chronic  HBV  infection  [3],  while
n estimated  200  million  people  (i.e.,  3.3%  of  the
orld’s population)  are  chronically  infected  by  HCV
orldwide  [4].  A  majority  of  countries  in  the  Mid-
le East  show  an  intermediate  or  high  endemicity  of
BV infection,  which  clearly  poses  a serious  public
ealth  problem  in  the  region  [5]. The  prevalence  of
BV and  HCV  in  Libya  has  been  recently  reported
n a  large  general  population-based  study  to  be
.2% for  HBsAg  and  1.8%  for  Anti-HCV  antibodies
6].
The modes  of  transmission  of  these  two  blood-
orne viruses  in  developing  countries  include
erinatal transmission  or  household  contact,  while
exual contact,  shared  needles  in  intravenous  drug
busers and  contaminated  blood  or  organ  trans-
lants are  responsible  for  their  transmission  in
eveloped  countries  [7].  However,  screening  tests
s well  as vaccination  for  HBV  have  dramatically
educed the  risk  of  transmission  worldwide  [8].
Occupational exposure  to  HBV  and  HCV  is  a well-
ecognized  risk  for  health  care  workers  (HCWs).
he assessment  of  the  risk  of  transmission  to  HCWs
equires  information  derived  from  various  sources
ncluding  the  place  of  HCW  hospital  work,  the  work-
ng period,  the  type  of  occupation,  and  the  rate  of
xposure to  patient  blood  and  blood  products  [9].
he rates  of  transmission  of  HBV  and  HCV  to  HCWs
re also  inﬂuenced  by  the  prevalence  of  HBV  and
CV infection  in  the  general  population.
l
u
i
wIn  developing  countries,  the  prevalence  of  HBV
nd HCV  among  HCWs  is high,  while  the  vaccination
tatus among  HCWs  and  its  relationship  with  occu-
ational factors  are  not  well  documented  [10,11].
ecause the  information  regarding  transmission  of
lood-borne  viruses  in  HCWs  is  very  limited  in  Libya
e decided  to  determine  the  frequency  of  HBV  and
CV transmission  to  HCWs  in  the  ﬁve  major  hospi-
als in  eastern  Libya.  A  further  aim  of  this  study
as to  analyze  how  the  risk  of  these  infections  are
ffected by  the  type  of  occupation,  the  place  of
ork in  the  hospital  and  the  working  period  as  well
s the  vaccination  status  among  this  high  risk  group.
aterials and methods
tudy population
he  present  study  was  conducted  from  July  2008
o June  2009  on  601  HCWs  from  ﬁve  major  hos-
itals in  the  three  main  cities  in  eastern  Libya.
here were  116,  120,  100,  152  and  113  HCWs  from
arious  professional  categories  who  were  randomly
elected  to  represent  the  1007,  455,  556,  405  and
80 HCWs  in  the  Aljomhoria  Hospital  and  Children’s
ospital (Benghazi),  Althawra  Hospital  (Albaida),
lwahda Hospital  (Derna),  and  Albutnan  Medical
enter (Tubruk),  respectively.
HCWs  were  deﬁned  as  workers  at  risk  of  needle
ticks or  other  sharps  injuries  in  the  hospitals.  This
eﬁnition  included  physicians,  dentists,  nurses,
idwives,  laboratory  technicians,  nursing  aids,abor rooms,  dental  clinics,  laboratories,  endoscopy
nits, nephrology  units,  coronary  care  units  (CCUs),
ntensive  care  units  (ICUs),  surgical  and  medical
ards, and  out-patient  departments,  as  well  as
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hospital  cleaners  and  workers  in  pharmacies  and
administration  departments.
Data collection
Demographic  and  epidemiological  data  were  col-
lected through  direct  personal  interviews  with  each
HCW carried  out  by  one  of  the  authors  (S.A.).  These
data include  sex,  age,  professional  activities  and
practices,  type  of  work,  place  and  duration  of  work
in the  hospital  as  well  as  any  history  of  hepatitis  B
vaccination.  The  data  were  anonymous  and  linked
to the  blood  sample  tube  only  by  a  code.
Sample collection and laboratory analysis:
A  blood  sample  (5—10  ml)  was  extracted  from  each
HCW and  transported  immediately  to  the  local  lab-
oratory, in  the  same  hospital  in  which  the  HCW
was working,  where  it  was  centrifuged  and  the
sera were  stored  at  −20 ◦C  until  transported  to
the Reference  Laboratory  for  Disease  Control  at
the National  Centre  for  Disease  Control  of  Libya
in Tripoli  city.  Samples  were  tested  for  HCV  mark-
ers using  the  enzyme  linked  immunosorbent  assay
(ELISA)  technique  (EIAgen  HCV  Ab  [v.4]  Adaltis,
Italy) according  to  the  manufacturer’s  instructions.
HBV markers  (i.e.,  HBeAg,  anti-HBe,  anti-HBs,
and total  anti-HBc)  were  detected  using  the
Enzyme Linked  Fluorescent  Assay  (ELFA)  (mini  Vidas
analyzer-BioMerieux,  France).  Both  the  HBsAg  and
Anti-HCV antibody  results  were  considered  posi-
tive (reactive)  or  negative  (non-reactive)  according
to the  interpretation  parameters  provided  by  the
manufacturers.  A  positive  control  and  a negative
control were  integrated  in  each  run  to  validate
the assay.  Polymerase  chain  reaction  (PCR)  was
also performed  for  all  HBsAg  and  anti-HCV  reactive
samples to  determine  the  levels  of  HBV-DNA  and
HCV-RNA  viremia,  respectively.  Both  HBV  and  HCV
markers,  as  well  as  PCR  assays,  were  performed
at the  Reference  Laboratory  for  Disease  Control  at
the National  Centre  for  Disease  Control  of  Libya,
Tripoli.
Ethical considerations
Ethical  approval  was  obtained  from  the  research
ethical committee  of  Al-Arab  Medical  University,
Benghazi, Libya.  The  study  was  conducted  in  accor-
dance with  the  Helsinki  Declaration  [12]  and  under
the supervision  of  the  National  Center  for  Disease
Control of  Libya.  All  participants  provided  written
informed  consent  before  the  collection  of  data  and
blood samples.
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tatistical analysis
he  data  were  analyzed  in  SPSS  statistical  soft-
are version  19.0.  Descriptive  statistics  in  the
orm of  the  mean  and  standard  deviations  and
he frequency  with  percentages  were  calculated
or interval  and  categorical  variables,  respectively.
he Chi-square  test  was  used  to  identify  differ-
nces between  categorical  variables  and  Student’s
-test  was  used  for  interval  variables  as  appro-
riate. The  results  were  considered  statistically
igniﬁcant when  the  p-value  (two-tailed)  was  less
han 0.05.
esults
he  cohort  was  comprised  of  601  HCWs  from
ve major  hospitals  in  eastern  Libya:  two  hospi-
als (Aljomhuria  Hospital  and  Children  Hospital)  in
enghazi (around  one  million  inhabitants);  Albeida
Althawra  Hospital);  Derna  (Alwahda  Hospital);  and
ubruk (Albutnan  Medical  Center).  There  was  a  pre-
ominance  of  females  (437,  72.3%),  the  majority  of
articipants (560,  93.2%)  were  Libyan,  and  41  indi-
iduals (6.8%)  were  non-Libyan.  The  mean  age  of
he cohort  was  32.90  ±  8.85  years  (range  =  17—60
ears). More  than  three  quarters  (78.6%)  of  the
tudied  HCWs  were  younger  than  40  years  of  age.
The overall  frequency  of  HBsAg  positivity  was
.8%  (11  HCWs).  However,  Anti-HBc,  HBeAg  and
nti-HBe  antibodies  were  found  in  8.5%,  0.7%  and
.0% of  participants,  respectively.  The  HBV-DNA
evel was  positive  in  55%  (6/11)  of  HBsAg-positive
CWs. Only  half  of  the  studied  HCWs  (51.4%)  were
mmune  to  HBV  infection  as  manifested  by  the
etection  of  Anti-HBs  antibodies.  The  overall  pos-
tivity of  Anti-HCV  antibodies  was  2.0%  (12  HCWs),
nd the  HCV-RNA  level  was  positive  in  four  (33.3%)
f these  samples.  The  distribution  of  hepatitis  B  and
 markers,  as  well  as  the  positivity  of  their  viremia,
s shown  for  the  HCWs  in  each  hospital  in  Table  1.
Only half  of  the  HCWs  (312,  52%)  received  full
accination  doses  (three  doses)  against  HBV  infec-
ion. Among  them,  the  efﬁciency  of  the  vaccine
s manifested  by  anti-HBs  positivity  was  approx-
mately  98.0%.  Table  2  shows  the  distribution  of
BsAg according  to  hepatitis  B  vaccine  status.  Of
he HCWs  who  had  not  received  any  vaccine,  3.9%
6/156)  were  HBsAg  positive  compared  to  only  1.3%
4/312) in  HCWs  who  had  received  one  or two  doses
f hepatitis  B  vaccine  (p  = 0.01  for  all  comparisons).
As shown  in  Table  3, nurses  and  nurse-aides  had
he highest  prevalence  rates  of  both  HBsAg  and
nti-HCV  antibody  among  the  studied  HCWs  (HBsAg:
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Table  2  HBsAg  positivity  according  to  the  hepatitis
B  vaccine  received  by  health  care  workers  (HCWs).
Vaccine  dose  received  by  HCWs  HBsAg  +veN  (%)
One  dose  (n  =  50)* 1  (2.0)
Two  doses  (n  =  79) 0 (0)
Three  and  four  doses  (n  =  312)* 4  (1.3)
Vaccine  not  received  (n  =  156)* 6  (3.9)
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ITotal  (n  =  601)  11  (1.8)
* p < 0.05 for all comparisons.
.1%  and  3.2%,  and  Anti-HCV  antibody:  3.2%  and
.9%, for  nurses  and  nurse-aides,  respectively).  It  is
oteworthy that  doctors  also  had  a relatively  high
revalence  rate  of  Anti-HCV  antibody  (2.2%).  More
han half  of  HCWs  were  Anti-HBs  antibody  positive.
ost of  this  positivity  is  due  to  vaccine  exposure
ather than  past  hepatitis  B  infections.
The distribution  of  HBV  markers  according  to  the
ork places  of  the  HCWs  was  also  studied.  HCWs
orking  on  gynecology  and  obstetric  wards,  surgical
ards,  medical  wards  and  dialysis  units  had  a higher
requency  of  infection  with  either  HBV  and/or  HCV
the prevalence  rate  varied  between  3%  and  5.6%)
ompared  to  other  work  site  categories  such  as  the
CU, CCU,  operating  rooms,  dental  clinics,  labora-
ories,  emergency  rooms,  OPD  and  isolation  wards
data not  shown).
Table  4  shows  the  distribution  of  hepatitis  B
nd C  markers  according  to  the  duration  of  time
articipants  spent  as  HCWs.  There  was  no  signiﬁ-
ant difference  between  HBsAg  status  and  the  work
eriod of  HCWs  (1.8%  for  >5  years  of  work  versus
.9% for  HCWs  with  a period  of  work  duration  less
han 5  years,  p  =  0.4  p  >  0.05).  However,  there  was
 trend  toward  increased  Anti-HCV  antibody  posi-
ivity among  those  HCWs  who  have  been  working
or more  than  5  years,  although  this  ﬁnding  did  not
each the  level  of  statistical  signiﬁcance  (2.5%  for
5 years  of  work  versus  1.4%  for  less  than  5 years
f work,  p =  0.08).
iscussion
ccording  to  the  World  Health  Organization  (WHO)
he proportion  of  HCWs  in  the  general  popula-
ion varies  substantially  from  region  to  region
0.2—2.5%), as  does  the  average  number  of  occu-
ational  injuries  per  HCWs  (for  example,  0.2—4.7%
harp  injuries  per  worker  per  year)  [13]. The
nnual proportion  of  HCWs  exposed  to  HBV  each
ear was  5.9%  for  HBV,  corresponding  to  approxi-
ately 66,000  HBV  infections  in  HCWs  worldwide.
n developing  countries,  40—65%  of  HBV  infections
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Table  3  Distribution  hepatitis  B  and  C  markers  according  to  the  type  of  occupation  of  the  health  care  workers.
Occupation  HBsAg  +ve HBcAb  +ve HBeAg  +ve Anti-HBe  +ve Anti-Hbs  +ve HBV-DNA  +ve Anti-HCV  +ve HCV-RNA  +ve
N  (%) N  (%) N  (%) N  (%) N  (%) N  (%) N  (%) N  (%)
Doctors  (n  =  134)  1  (0.7)  10  (29.4)  2  (1.5)  7  (5.2)  84  (62.7)  0  (0.0)  3  (2.2)  1  (0.7)
Lab  technicians  (n  =  110)  1  (0.9)  4  (3.6)  0  (0.0)  7  (6.4)  70  (63.6)  1  (0.9)  0  (0.0)  0  (0.0)
Nurses  (n  =  188)  4  (2.1)  19  (10.1)  2  (1.1)  20  (10.6)  98  (52.1)  3  (1.6)  6  (3.2)  1  (0.5)
Nurse-aides  (n  =  61)  2  (3.3)  8  (13.1)  0  (0.0)  7  (11.5)  22  (36.1)  1  (1.6)  3  (4.9)  2  (3.3)
Hospital  cleaners  (n  =  70)  1  (1.4)  8  (11.4)  0  (0.0)  5  (7.1)  28  (40.0)  0  (0.0)  0  (0.0)  0  (0.0)
Anesthesia  technicians  (n  =  13)  1  (7.7)  1  (7.7)  0  (0.0)  1  (7.7)  8  (61.5)  1  (7.7)  0  (0.0)  0  (0.0)
Others  (n  =  25)  1  (4.0)  1  (4.0)  0  (0.0)  1  (4.0)  3  (12.0)  0  (0.0)  0  (0.0)  0  (0.0)
Total  (n  =  601)  11  (1.8)  51  (8.5)  4  (0.7)  48  (8.0)  309  (51.4)  6  (1.0)  12  (2.0)  4  (0.7)
Table  4  Distribution  of  hepatitis  B  and  C  markers  according  to  the  duration  of  the  work  period  of  health  care  workers.
Work  period  HBsAg  +ve  HBcAb  +ve  HBeAg  +ve  Anti-HBe  +ve  Anti-HBs  +ve  HBV-DNA  +ve  Anti-HCV  +ve  HCV-RNA  +ve
N  (%)  N  (%)  N  (%)  N  (%)  N  (%)  N  (%)  N  (%)  N  (%)
0—5  years  (n  =  280)* 5  (1.8)  14  (1.75)  3 (1.1)  13  (4.6)  123  (43.9)  3  (1.0)  4  (1.4)  1  (0.4)
>5  years  (n  =  321)* 6  (1.9)  37  (11.5)  1 (0.3)  35  (10.9)  186  (57.9)  3  (0.9)  8  (2.5)  3  (0.9)
Total  (n  =  601) 11  (1.8) 51  (8.5)  4 (0.7)  48  (8.0)  309  (51.4)  6  (1.0)  12  (2.0)  4  (0.7)
* No signiﬁcant difference.
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tepatitis  B and  C  in  health  care  workers  in  Libya  
n  HCWs  are  attributable  to  percutaneous  occu-
ational exposure.  By  contrast,  in  developed
ountries, the  exposure  rate  was  less  than  10%,
argely due  to  high  rates  of  immunization  and  the
vailability  of  post-exposure  prophylaxis  [14]. The
trengths of  the  present  study  include  the  fact
hat it  involved  multiple  centers,  which  allowed
s to  identify  the  seroprevalence  of  HBV  and  HCV,
he working  period,  and  the  different  occupational
isks of  acquiring  infection  in  HCWs  in  ﬁve  differ-
nt sites  in  eastern  Libya.  The  lower  prevalence  of
BsAg (1.8%)  was  similar  to  data  from  a  national
opulation-based  sero-epidemiological  survey  that
ound that  the  overall  prevalence  of  HBV  was  2.2%
6].  Two  previous  local  studies  carried  out  in  Libya
ave found  that  31%  and  14.8%  of  HCWs  in  Tripoli
nd Benghazi,  respectively,  were  infected  [15,16],
nd the  low  prevalence  among  HCWs  in  the  present
tudy  might  be  explained  by  their  awareness  of
he routes  of  HBV  transmission,  the  implementation
f infection  control  measures  and  a  free  vaccina-
ion program.  Numerous  sero-prevalence  studies
ave documented  the  risks  of  HCWs  of  contract-
ng hepatitis  B.  Rates  in  our  cohort  exceeded  those
eported  in  Brazil  (0.8%),  Egypt  (1.5%)  and  Morocco
1%) [17—19].  Moreover,  HCWs  are  reported  to  have
 lower  (1%)  prevalence  of  HBsAg  compared  to
oroccan blood  donors  (1%  versus  2%)  (17)  [17—19].
n contrast,  we  observed  lower  prevalence  rates
han those  found  in  Syria  (6%),  Cameroon  (23.6%),
igeria  (13%),  Pakistan  (2.18%)  and  Uganda  (8.1%)
20—24].  Anti-HBc,  HBeAg  and  Anti-HBe  antibodies
ere found  in  8.5%,  0.7%  and  8.0%,  respectively.
imilar positive  anti-HBc  serological  results  were
ound  in  Brazil  by  Luiz  et  al.,  9.4%  [19].  Only  half
f the  studied  HCWs  (51.4%)  were  immune  to  HBV
nfection  as  manifested  by  the  detection  of  Anti-
Bs antibodies.  These  results  show  that  half  of  the
tudied  HCWs  could  have  contracted  HBV  after  a
eedle stick  injury  involving  an  HBV  carrier’s  blood.
ecently,  Ziglam  et  al.  [25]  have  demonstrated
hat only  21.8%  (591/2704  of  HCWs)  had  anti-HBs
ntibody  concentrations  (less  than  10  U/ml)  in  a
ertiary care  hospital  in  Tripoli,  Libya.
This  survey  shows  that  one  in  ﬁfty  (N  =  12)  of
he HCWs  employed  in  high-risk  environments  had
nti-HCV  antibodies  (2.0%),  and  HCV-RNA  as  mea-
ured by  PCR  was  positive  in  four  (33.3%)  of  these
CWs.  Various  studies  detected  substantially  differ-
nt results:  in  Cameroon  (16%),  Egypt  (16.6%,  with
CV-RNA  detected  in  72.1%  of  the  samples),  and
yria (3%),  while  in  Poland,  1.7%,  with  HCV-RNA
etected in  3 out  of  these  16  (19%)  sera  sam-
les [18,20,22,26].  It  has  been  suggested  that  the
eported  risk  of  HCV  infection  following  occupa-
ional exposure  is  low,  with  seroconversion  rates
h
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etween  0%  and  5%,  with  <1%  as  the  most  com-
only reported  rate  [27,28]. Recently,  a study
erformed  in  Italy  focusing  on  the  HCV  knowledge
nd attitudes  and  exploring  the  evidence-based
ractices for  the  prevention  of  HCV  has  recom-
ended that  behavior  changes  should  be  aimed
t abandoning  outdated  practices  and  adopting
nd maintaining  evidence-based  practices  [29].
ur results  described  a  higher  rate  of  HCV  anti-
ody positivity  than  a large  scale  multi-staged
tudy covering  more  than  65,000  individuals  of
ll age  groups  from  the  whole  of  Libya,  in  which
he prevalence  of  Anti-HCV  antibodies  was  1.3%
6]. This  might  be  explained  by  the  risks  of
ccupational blood  exposure  such  as  needle  stick
njuries.
Nurses  and  nurse-aides  have  had  the  highest
revalence rates  of  both  HBsAg  and  Anti-HCV
mong the  studied  HCWs  (HBsAg:  2.1%  and  3.2%
nd Anti-HCV  antibody:  3.2%  and  4.9%,  for  nurses
nd nurse-aides,  respectively).  It  is  noteworthy
hat doctors  also  had  a relatively  high  preva-
ence rate  of  Anti-HCV  antibodies  (2.2%);  it  has
een demonstrated  that  doctors/surgeons  have  the
ighest risk  of  HBV  infection  from  their  patients
30—32].
More than  half  of  HCWs  were  Anti-HBs  anti-
ody positive,  and  most  of  this  positivity  is due  to
accine exposure  rather  than  past  hepatitis  B  infec-
ion. The  variations  among  the  different  cadres
f HCWs  might  be  a  reﬂection  of  the  different
evels of  exposure  and  the  hazardous  work  envi-
onments  that  the  different  categories  of  HCWs
perate in.  This  ﬁnding  is in  line  with  other  stud-
es [15,21].  Assessing  HBV  vaccination  coverage  in
he health  care  setting  is  needed  to  evaluate  the
roportion  of  workers  susceptible  to  HBV  infec-
ion [33]. In  Libya,  while  hepatitis  B  vaccination
as added  to  the  expanded  program  on  immuniza-
ion (EPI)  in  1993,  it  is  not  mandatory  for  HCWs.
herefore, it is  the  employee’s  responsibility  to
ontinue the  vaccination  schedule.  A  threshold  of
ero-positivity  of  10  U/ml  was  chosen,  as  recom-
ended by  the  United  States  Advisory  Committee
n Immunization  Practices  and  the  WHO  [34].  We
ave shown  that  only  half  of  the  HCWs  (52%)  com-
lete the  full  vaccination  regimen  (three  doses)
gainst HBV  infection.  Among  them,  the  efﬁciency
f the  vaccine  as  manifested  by  anti-HBc  positivity
as approximately  98.0%.  Among  HCWs  that  did
ot receive  any  vaccine,  3.9%  were  HBsAg  posi-
ive compared  to  only  1.3%  in  those  HCWs  who
ad received  incomplete  hepatitis  B  vaccination
p <  0.05  for  all  comparisons).  A  previous  study  con-
ucted in  Tripoli,  Libya  found  that  78.2%  of  the
CWs were  vaccinated  [25]. The  HBV  vaccination
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rates  among  HCWs  in  the  Middle  East  and  other
countries with  low  socioeconomic  status  have  been
reported  to  be  unsatisfactory  [35].  According  to
the WHO  estimates,  vaccination  rates  vary  from
18% in  Africa  to  77%  in  Australia  and  New  Zealand
[14].  In  the  United  States,  75%  of  the  HCWs  at
risk had  received  three  or  more  doses  of  vaccine
[36].
The distribution  of  HCV  and  HBV  markers  accord-
ing to  the  categories  of  HCWs  was  also  studied.  ICU,
CCU, isolation  rooms  or  operating  rooms  were  the
work places  found  to  be  associated  with  HBV  infec-
tion. Meanwhile,  the  surgical  wards,  medical  wards
and dialysis  units  were  the  work  places  with  a  higher
frequency  of  HCV-infected  HCWs.  A  high  prevalence
rate of  both  HBV  and  HCV  were  detected  among
gynecologists and  obstetricians,  and  the  prevalence
of HBV  was  found  to  be  extremely  high  (80%)  among
this population  [24]. Ziraba  et  al.  [21]  concluded
that laboratory  technicians  are  more  likely  to  be
exposed  to  HBV,  but  in  this  study  the  frequency  of
HBV exposure  was  markedly  low  among  laboratory
technicians (0.8%).
The  current  study  investigated  the  distribution
of hepatitis  B  and  C  markers  according  to  the  work
duration  of  the  HCWs.  There  was  no  signiﬁcant  dif-
ference  between  HBsAg  status  and  the  work  period
of HCWs  (1.8%  for  >5  years  of  work  versus  1.9%  for
less than  5 years  of  work,  p  >  0.05).  However,  there
was a  trend  of  increased  Anti-HCV  antibody  posi-
tivity among  those  HCWs  who  have  been  working
for periods  of  more  than  5  years.  Similar  results
of higher  Anti-HCV  antibody  positivity  were  found
among older  HCWs  [18].  Another  study  found  that
the age  and  employment  duration  strongly  corre-
lated with  HBV  prevalence  [23]. Recently,  a study
carried  out  in  Poland  found  that  HBV  occurred  most
frequently  during  the  periods  of  15—19,  20—24  and
25—29 years  of  employment  (50%  of  cases),  and  it
was lower  for  women  than  for  men  by  1.71  years
(18.2 years  versus  19.9  years)  [37].
The limitations  of  our  study  are  the  size  of  our
population sample  due  to  limited  funding  and  the
cost of  biological  testing.  Therefore,  we  had  low
numbers  of  HCWs  in  some  settings  (particularly  in
ICU and  dialysis  units).  In  addition,  we  did  not
determine the  category  of  vaccinated  and  unvac-
cinated individuals.
In conclusion,  knowing  the  status  of  HBV  and  HCV
infections  among  HCWs,  the  need  for  preventive
measures (standard  precautions)  and  enforcing  vac-
cination against  HBV  are  recognized  as  fundamental
factors to  protect  this  high  risk  group  against  these
diseases.  Moreover,  the  study  explored  that  HBV
vaccines  should  be  more  readily  available  for  Libyan
HCWs by  reinforcing  current  vaccination  programs.
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